NuScale Power Faces Class Action Lawsuit Over Misleading Statements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 19 2026
0mins
Should l Buy SMR?
Source: Businesswire
NuScale Power Corp's stock has dropped 6.19% and hit a 52-week low amid ongoing legal troubles.
The company is facing a class action lawsuit initiated by Bernstein Liebhard LLP, alleging misrepresentations regarding its partnership with ENTRA1 Energy LLC. The lawsuit claims that NuScale's management failed to disclose critical information about ENTRA1's lack of experience in nuclear projects, which may have misled investors and contributed to the stock's decline. Investors are encouraged to file papers by April 20, 2026, to participate in the lawsuit, highlighting the potential for significant financial implications for the company.
This legal action reflects growing investor concerns about NuScale's financial transparency and management practices, which could further impact its stock performance and investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SMR
Wall Street analysts forecast SMR stock price to rise
13 Analyst Rating
5 Buy
6 Hold
2 Sell
Hold
Current: 11.410
Low
18.50
Averages
32.77
High
60.00
Current: 11.410
Low
18.50
Averages
32.77
High
60.00
About SMR
NuScale Power Corporation is a provider of proprietary advanced small modular reactor (SMR) nuclear technology. The NuScale Power Module, the Company's SMR technology, is a small pressurized water reactor that can generate approximately 77 megawatts of electricity (MWe) or 250 megawatts thermal (gross) and can be scaled to meet customer needs through an array of flexible configurations of up to 924 MWe (12 modules) of output. In addition to the sale of NPMs, it offers a diversified suite of services throughout the development and operating life of the power plant. The Company's suite of services is planned to include licensing support, testing, training, fuel supply services and program management, among others. It serves a range of customers consisting of domestic and international governments, utilities, state-owned enterprises and technology and industrial companies in need of carbon-free, reliable energy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
NuScale Power Shares Surge 44.4% Amid Nuclear Energy Renaissance
- Stock Surge: NuScale Power's shares soared 44.4% at their peak this week, indicating a significant shift in market sentiment towards the nuclear energy sector, reflecting increasing investor interest in small modular reactors (SMRs).
- Policy Support: On April 14, the White House unveiled the National Initiative for American Space Nuclear Power, aiming to deploy nuclear reactors in orbit by 2028, demonstrating strong governmental backing for nuclear energy development and enhancing NuScale Power's market outlook.
- Major Investment: On the same day, the U.K. government announced approximately £599 million (around $800 million) in funding for Rolls-Royce's SMR program, signaling a rising global demand for SMRs, thereby reinforcing NuScale Power's commercial viability.
- Market Outlook: Although NuScale Power's fundamentals remain unchanged and it faces issues with its exclusive commercialization partner ENTRA1 Energy, the improving perception of nuclear energy may attract more investor interest in the company.
See More
Reminder for NuScale Power Class Action Lawsuit
- Class Action Notice: Rosen Law Firm reminds investors who purchased NuScale Power Class A common stock between May 13, 2025, and November 6, 2025, to apply as lead plaintiffs by April 20, 2026, to participate in the class action and potentially receive compensation.
- Fee Arrangement: Participants can obtain compensation without any upfront costs through a contingency fee arrangement, which reduces the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that NuScale failed to disclose ENTRA1 Energy LLC's lack of experience in the nuclear sector during the class period, exposing investors to significant risks that could impact the company's future commercialization strategy.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, prompting investors to carefully select qualified legal counsel.
See More
NuScale Power Faces Financial Challenges Amid Market Sell-off
- Stock Price Decline: Since the beginning of 2026, NuScale Power's shares have lost nearly 30% of their value, despite a 15% single-day gain on April 15, indicating market concerns about its future prospects that could undermine investor confidence.
- Significant Losses: The company reported a net loss exceeding $660 million last year, marking its fourth consecutive year of losses, which highlights the financial strain in developing small modular reactors (SMRs) and may limit its ability to raise capital.
- Bleak Profitability Outlook: Analysts do not expect NuScale Power to achieve profitability in the next two fiscal years, with potential profitability not anticipated until this decade, increasing reliance on external capital during market downturns and heightening financial risks.
- Capital Raising Challenges: With its market cap plummeting from $8 billion to $4 billion, NuScale Power faces a tougher fundraising environment, likely resulting in higher borrowing costs and shareholder dilution risks, further impacting its operational and growth plans.
See More
NuScale Power Faces Profitability Challenges Amid Market Sell-off
- Poor Market Performance: Since the beginning of 2026, NuScale Power's stock has lost nearly 30% of its value, despite a 15% single-day gain on April 15, indicating a troubling trend that may undermine investor confidence regarding its future profitability.
- Escalating Financial Losses: The company reported a net loss exceeding $660 million last year, marking its fourth consecutive year of losses, and analysts predict it will remain unprofitable for at least the next two fiscal years, increasing reliance on external capital to sustain operations.
- Capital Raising Challenges: Following a market sell-off, NuScale Power's market cap has plummeted to $4 billion from $8 billion just months ago, complicating its ability to secure loans under favorable terms, while the risk of shareholder dilution looms larger at lower stock prices.
- Slow Technological Progress: Although the small modular reactor (SMR) market holds significant potential, estimated at $10 trillion, NuScale Power's first facility may not be operational until 2030 at the earliest, with the technology yet to achieve meaningful scale, placing the company at a competitive disadvantage.
See More
Fluor Corporation Discloses 3.9% Ownership in NuScale Power Corp as of April 15, Down from 7.8% on April 9, According to Filing
Stakeholder Update: Fluor Corporation reports a decrease in its stake in NuScale Power Corporation to 3.9% as of April 15.
Previous Stake Comparison: This is a reduction from a prior stake of 7.8% reported on April 9.
See More
Multiple Companies Face Class Action Lawsuits
- PayPal Lawsuit Overview: From February 2024 to February 2026, PayPal is accused of overstating its ability to execute business initiatives, misleading investors about its prospects, with a lead plaintiff motion deadline set for April 20, 2026.
- NuScale Power Risk Disclosure: During the period from May to November 2025, NuScale Power allegedly failed to disclose significant risks associated with its nuclear projects, prompting investors to act by April 20, 2026, indicating a loss of confidence in the company's future.
- Corcept Therapeutics Regulatory Issues: Between October 2024 and December 2025, Corcept is accused of not disclosing FDA concerns regarding the effectiveness assessment of its drug, misleading investors about its business outlook, with a lead plaintiff motion deadline of April 21, 2026.
- Navan, Inc. IPO Controversy: Navan is accused of failing to disclose a 39% increase in sales and marketing expenses during its 2025 IPO, negatively impacting its revenue and market performance, with a lead plaintiff motion deadline of April 24, 2026.
See More
NuScale Power Shares Surge 44.4% Amid Nuclear Energy Renaissance
- Stock Surge: NuScale Power's shares soared 44.4% at their peak this week, indicating a significant shift in market sentiment towards the nuclear energy sector, reflecting increasing investor interest in small modular reactors (SMRs).
- Policy Support: On April 14, the White House unveiled the National Initiative for American Space Nuclear Power, aiming to deploy nuclear reactors in orbit by 2028, demonstrating strong governmental backing for nuclear energy development and enhancing NuScale Power's market outlook.
- Major Investment: On the same day, the U.K. government announced approximately £599 million (around $800 million) in funding for Rolls-Royce's SMR program, signaling a rising global demand for SMRs, thereby reinforcing NuScale Power's commercial viability.
- Market Outlook: Although NuScale Power's fundamentals remain unchanged and it faces issues with its exclusive commercialization partner ENTRA1 Energy, the improving perception of nuclear energy may attract more investor interest in the company.
See More
Reminder for NuScale Power Class Action Lawsuit
- Class Action Notice: Rosen Law Firm reminds investors who purchased NuScale Power Class A common stock between May 13, 2025, and November 6, 2025, to apply as lead plaintiffs by April 20, 2026, to participate in the class action and potentially receive compensation.
- Fee Arrangement: Participants can obtain compensation without any upfront costs through a contingency fee arrangement, which reduces the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that NuScale failed to disclose ENTRA1 Energy LLC's lack of experience in the nuclear sector during the class period, exposing investors to significant risks that could impact the company's future commercialization strategy.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, prompting investors to carefully select qualified legal counsel.
See More
NuScale Power Faces Financial Challenges Amid Market Sell-off
- Stock Price Decline: Since the beginning of 2026, NuScale Power's shares have lost nearly 30% of their value, despite a 15% single-day gain on April 15, indicating market concerns about its future prospects that could undermine investor confidence.
- Significant Losses: The company reported a net loss exceeding $660 million last year, marking its fourth consecutive year of losses, which highlights the financial strain in developing small modular reactors (SMRs) and may limit its ability to raise capital.
- Bleak Profitability Outlook: Analysts do not expect NuScale Power to achieve profitability in the next two fiscal years, with potential profitability not anticipated until this decade, increasing reliance on external capital during market downturns and heightening financial risks.
- Capital Raising Challenges: With its market cap plummeting from $8 billion to $4 billion, NuScale Power faces a tougher fundraising environment, likely resulting in higher borrowing costs and shareholder dilution risks, further impacting its operational and growth plans.
See More
NuScale Power Faces Profitability Challenges Amid Market Sell-off
- Poor Market Performance: Since the beginning of 2026, NuScale Power's stock has lost nearly 30% of its value, despite a 15% single-day gain on April 15, indicating a troubling trend that may undermine investor confidence regarding its future profitability.
- Escalating Financial Losses: The company reported a net loss exceeding $660 million last year, marking its fourth consecutive year of losses, and analysts predict it will remain unprofitable for at least the next two fiscal years, increasing reliance on external capital to sustain operations.
- Capital Raising Challenges: Following a market sell-off, NuScale Power's market cap has plummeted to $4 billion from $8 billion just months ago, complicating its ability to secure loans under favorable terms, while the risk of shareholder dilution looms larger at lower stock prices.
- Slow Technological Progress: Although the small modular reactor (SMR) market holds significant potential, estimated at $10 trillion, NuScale Power's first facility may not be operational until 2030 at the earliest, with the technology yet to achieve meaningful scale, placing the company at a competitive disadvantage.
See More
Fluor Corporation Discloses 3.9% Ownership in NuScale Power Corp as of April 15, Down from 7.8% on April 9, According to Filing
Stakeholder Update: Fluor Corporation reports a decrease in its stake in NuScale Power Corporation to 3.9% as of April 15.
Previous Stake Comparison: This is a reduction from a prior stake of 7.8% reported on April 9.
See More
Multiple Companies Face Class Action Lawsuits
- PayPal Lawsuit Overview: From February 2024 to February 2026, PayPal is accused of overstating its ability to execute business initiatives, misleading investors about its prospects, with a lead plaintiff motion deadline set for April 20, 2026.
- NuScale Power Risk Disclosure: During the period from May to November 2025, NuScale Power allegedly failed to disclose significant risks associated with its nuclear projects, prompting investors to act by April 20, 2026, indicating a loss of confidence in the company's future.
- Corcept Therapeutics Regulatory Issues: Between October 2024 and December 2025, Corcept is accused of not disclosing FDA concerns regarding the effectiveness assessment of its drug, misleading investors about its business outlook, with a lead plaintiff motion deadline of April 21, 2026.
- Navan, Inc. IPO Controversy: Navan is accused of failing to disclose a 39% increase in sales and marketing expenses during its 2025 IPO, negatively impacting its revenue and market performance, with a lead plaintiff motion deadline of April 24, 2026.
See More
